MRCP UK EXAMINATIONS

RESPIRATORY

PATIENT WITH PREVIOUS LUNG SURGERY

Question [CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
The current treatment of choice for small cell lung cancer is:-
A
Radiation alone.
B
Alpha interferon alone
C
.Combination of chemotherapy.
D
Surgical resection and interleukin 3.
Explanation: 

Detailed explanation-1: -Generally, SCLC is treated with combinations of chemo drugs. The combinations used most often are: Cisplatin and etoposide. Carboplatin and etoposide.

Detailed explanation-2: -Chemotherapy and radiation therapy Combined-modality treatment with etoposide and cisplatin with thoracic radiation therapy (TRT) is the most widely used treatment for patients with limited-stage disease (LD) SCLC.

Detailed explanation-3: -Usually, SCLC is treated with a combination of chemotherapy drugs: Etoposide (available as a generic drug) and cisplatin (available a a generic drug) Etoposide and carboplatin (available as a generic drug) Irinotecan (Camptosar) and cisplatin.

Detailed explanation-4: -Patients with limited-stage (ls) or extensive-stage (es) small-cell lung cancer (sclc) are commonly given platinum-based chemotherapy as first-line treatment. Standard chemotherapy for patients with ls sclc includes a platinum agent such as cisplatin combined with the non-platinum agent etoposide.

Detailed explanation-5: -Although small cell lung cancer is an aggressive disease, it responds well to initial chemotherapy and radiation. The goal of treatment for people with limited-stage small cell lung cancer is cure, which is achieved in 20 to 25 percent of patients.

There is 1 question to complete.